👦 Low-Dose Atropine Eye Drops Simulator

Blocking Muscarinic Receptors to Slow Scleral Remodeling

Atropine antagonizes M1-M4 receptors, placeholder mechanism sentence here.

• M1–M4: Receptor subtypes (placeholder short note)
• Sclera: Target tissue (placeholder short note)
• ~1 hr: Onset (placeholder short note)
• Antimuscarinic: Class (placeholder short note)

Receptor blockade pathway

Placeholder sentence describing muscarinic receptor blockade in the retina and sclera.

Nightly Low-Concentration Drop Dosing Protocol

A single low-dose drop is instilled nightly in each eye, placeholder sentence.

• 0.01–0.05%: Dose range (placeholder short note)
• 1×/night: Frequency (placeholder short note)
• Multi-year: Duration (placeholder short note)
• ATOM2/LAMP: Trial (placeholder short note)

Administration schedule

Placeholder sentence describing dosing schedule and delivery method.

Flattening the Axial Length Growth Curve

Treated eyes elongate more slowly than untreated eyes, placeholder sentence.

• 30–60%: Reduction range (placeholder short note)
• mm/year: Measure (placeholder short note)
• Biometry: Method (placeholder short note)
• 2 years: Follow-up (placeholder short note)

Elongation rate comparison

Placeholder sentence comparing treated vs untreated axial elongation trend.

Pupil Dilation and Light Sensitivity Trade-off

Higher concentrations cause more pupil dilation and photophobia, placeholder sentence.

• up to 1.5mm: Pupil increase (placeholder short note)
• dose-dependent: Photophobia (placeholder short note)
• minimal loss: Accommodation (placeholder short note)
• Photochromic lens: Mitigation (placeholder short note)

Side effect profile

Placeholder sentence describing dilation and photophobia side effects.

Choosing a Concentration That Balances Efficacy and Comfort

Clinicians balance concentration against side effects, placeholder sentence.

• 0.01%: Low dose (placeholder short note)
• 0.025%: Mid dose (placeholder short note)
• 0.05%: High dose (placeholder short note)
• ~0.02–0.03%: Best balance (placeholder short note)

Dose-response trade-off

Placeholder sentence summarizing the concentration efficacy-safety balance.

Placeholder key-insight sentence about optimal dosing balance.